Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Applied DNA Sciences Inc.

    NASDAQ: APDN · Real-Time Price · USD
    0.90
    -0.01 (-1.10%)
    At close: May 02, 2025, 3:56 PM
    0.92
    2.29%
    Pre-market: May 05, 2025, 04:00 AM EDT
    -1.10%
    Bid 0.9
    Market Cap 5.84M
    Revenue (ttm) 3.74M
    Net Income (ttm) -8.53M
    EPS (ttm) -32.5
    PE Ratio (ttm) -0.03
    Forward PE -0.17
    Analyst Buy
    Ask 0.93
    Volume 257,394
    Avg. Volume (20D) 1,250,778
    Open 0.91
    Previous Close 0.91
    Day's Range 0.87 - 0.92
    52-Week Range 0.72 - 237.50
    Beta 0.84

    About APDN

    Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection ...

    [Read more]
    Industry Medical - Diagnostics & Research
    Sector Healthcare
    IPO Date Jul 15, 2003
    Employees 46
    Stock Exchange NASDAQ
    Ticker Symbol APDN
    Website https://www.adnas.com
    Full Company Profile

    Analyst Forecast

    According to 1 analyst ratings, the average rating for APDN stock is "Buy." The 12-month stock price forecast is $75, which is an increase of 8238.89% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    1 month ago
    +1.2%
    Applied DNA Sciences shares are trading higher aft... Unlock content with Pro Subscription
    1 month ago
    -56.73%
    Applied DNA Sciences shares are trading lower after the company announced a 1-for-50 reverse stock split.
    news image

    1 week ago · accessnewswire.com

    Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA

    - Pivot to U.S.-based Supply Chain for Critical Input Materials Completed - STONY BROOK, NY / ACCESS Newswire / April 21, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company")...

    news image

    3 weeks ago · accessnewswire.com

    Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

    STONY BROOK, NY / ACCESS Newswire / April 8, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that on April 7, 2025, it received a...

    news image

    1 month ago · accessnewswire.com

    Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement

    - Company Revamps Pharmacogenomics Go-To-Market Strategy, Targets Validated PGx Assay Towards Specific Use Cases - STONY BROOK, NY / ACCESS Newswire / April 1, 2025 / Applied DNA Sciences, Inc. (NASDA...

    news image

    1 month ago · accessnewswire.com

    Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test

    STONY BROOK, NY / ACCESS Newswire / March 26, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), a leader in PCR-based DNA technologies, today announced that Applied DNA C...

    news image

    1 month ago · accessnewswire.com

    Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025

    STONY BROOK, NY / ACCESS Newswire / March 12, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), a leader in PCR-based DNA technologies, today announced that it will effec...

    news image

    2 months ago · seekingalpha.com

    Applied DNA Sciences, Inc. (APDN) Q1 2025 Earnings Call Transcript

    Applied DNA Sciences, Inc. (NASDAQ:APDN ) Q1 2025 Earnings Conference Call February 13, 2025 4:30 PM ET Company Participants Sanjay Hurry - Executive Director, IR & Corporate Communications Beth Jantz...

    news image

    2 months ago · zacks.com

    Applied DNA Sciences (APDN) Reports Q1 Loss, Tops Revenue Estimates

    Applied DNA Sciences (APDN) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $1.80 per share a year ago.

    news image

    2 months ago · accessnewswire.com

    Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress

    - Announces Exit of DNA Tagging and Security Products and Services Business Segment - - Workforce Reduction of 20% of Headcount Implemented in January - - GMP Site 1 Facility Complete and Certified fo...

    news image

    2 months ago · accessnewswire.com

    Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025

    Investor Call and Webcast Scheduled for 4:30 P.M ET STONY BROOK, NY / ACCESS Newswire / February 12, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polym...

    news image

    2 months ago · accessnewswire.com

    Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14

    STONY BROOK, NY / ACCESS Newswire / February 11, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today issued a reminder to it...

    Add to Watchlist